MLND News and Press, Millendo Therapeutics From 06/23/20

Millendo slumps ( MLND -13.5% ) on modestly higher volume after the company announced that it will be terminating development of nevanimibe for congenital adrenal hyperplasia (CAH). More news on: Millendo Therapeutics, Inc., Healthcare stocks news, Stocks on the move, Read more ...

– MLE-301, a selective neurokinin 3 receptor (NK3R) antagonist, advancing with first-in-human trials expected to initiate in 3Q20 – – Further investment in nevanimibe for congenital adrenal hyperplasia (CAH) not planned following interim data review – &...

Francesca's Holdings (NASDAQ: FRAN )  -24%  on Q1 results . More news on: Francesca's Holdings Corporation, Medley Management Inc., Brickell Biotech, Inc., Stocks on the move, , Read more ...

2 Small Cap Stocks To Watch Before Friday Like it or not, small-cap stocks have emerged as a popular asset class to watch this quarter. More specifically, small-cap biotech stocks are making big moves like never before. For this reason, it is gathering a lot of gamblers and crypto traders ...

Carver Bancorp (NASDAQ: CARV ) +232% . More news on: Carver Bancorp, Inc., Urban One, Inc., Energous Corporation, Stocks on the move, , Read more ...

Westwater Resources (NASDAQ: WWR ) +144%  on positive independent test results on ULTRA-PMG. More news on: Westwater Resources, Inc., Tenax Therapeutics, Inc., BioHiTech Global, Inc., Stocks on the move, , Read more ...

3 Penny Stocks To Watch Right Now Putting your money into penny stocks can be exciting and scary at the same time. Exciting because penny stocks offer high potential for large gains. Scary because these high flying penny stocks are also highly risky too. But if you can handle a little bit of...

 Gainers:  Sonoma Pharmaceuticals (NASDAQ: SNOA ) +145% . More news on: Sonoma Pharmaceuticals, Inc., Adaptimmune Therapeutics plc, Phio Pharmaceuticals Corp., Stocks on the move, , Read more ...

Millendo Therapeutics (NASDAQ: MLND ): Q1 GAAP EPS of -$0.65 beats by $0.02 . More news on: Millendo Therapeutics, Inc., Earnings news and commentary, , Read more ...

Millendo Therapeutics, Inc. (Nasdaq:MLND), a clinical stage biopharmaceutical company primarily focused on developing novel treatments for endocrine diseases with significant unmet needs, today provided a corporate update and reported financial results for the quarter ended March 31, 2020. ...